Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman

SAN FRANCISCO, Nov. 18, 2025 /PRNewswire/ -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced its Q3 2025 financial results and revealed cancelation of emerging markets distributor orders, prompting one analyst to question management's guidance philosophy.

Read more at prnewswire.com